CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
EnglishAims The ErbB-neuregulin1beta1 (Nrg1beta1) pathway is required for cardiac development and exerts chronic effects on the postnatal adult heart. Long term application results in hypertrophy and protection against oxidative stress and cytotoxic agents. We performed experiments with Nrg1beta1 acute treatment to find evidence for a further protective role due to rapid modulation of adult cardiomyocytes function. Methods and Results in confocal fluorimetric measurements Nrg1beta1 induced a calcium independent increase in nitric oxide (NO) production in isolated adult rat ventricular myocytes (ARVCMs), blocked by the phosphoinositide-3-kinase (PI3K) inhibitor Wortmannin (Wm). Western blot analysis showed enhancement in endothelial Nitric Oxide Synthase (eNOS) phosphorylation in Nrg1beta1 treated ARVCMs, attenuated by Wm. Nrg1beta1 induced a significant increase in calcium transient amplitude (indo-1 ratiometric measure) and accelerated the recovery of cytosolic calcium in the sarcoplasmic reticulum (SR) without affecting whole cell L-Type calcium current. Wm or the Protein Kinase-G (PKG) inhibiting peptide (DT-2) abolished the increase in calcium transient amplitude and the acceleration of calcium recovery induced by Nrg1beta1 treatment. Immunofluorescence analysis revealed that Nrg1beta1 treatment increased phospholamban phosphorylation and the effect was blocked by PI3K and PKG inhibition. Caffeine releasable SR calcium content was also higher during Nrg1beta1 administration. Conclusion Rapid activation of PI3K, eNOS and PKG and a consequent improvement in diastolic calcium can therefore be added to established Nrg1 protective roles.
| Titolo: | Neuregulin-1{beta}1 rapidly modulates nitric oxide synthesis and calcium handling in rat cardiomyocytes. | |
| Autori Riconosciuti: | ||
| Autori: | Brero A; Ramella R; Fitou A; Dati C; Alloatti G; Gallo MP; Levi R. | |
| Data di pubblicazione: | 2010 | |
| Abstract: | Aims The ErbB-neuregulin1beta1 (Nrg1beta1) pathway is required for cardiac development and exerts chronic effects on the postnatal adult heart. Long term application results in hypertrophy and protection against oxidative stress and cytotoxic agents. We performed experiments with Nrg1beta1 acute treatment to find evidence for a further protective role due to rapid modulation of adult cardiomyocytes function. Methods and Results in confocal fluorimetric measurements Nrg1beta1 induced a calcium independent increase in nitric oxide (NO) production in isolated adult rat ventricular myocytes (ARVCMs), blocked by the phosphoinositide-3-kinase (PI3K) inhibitor Wortmannin (Wm). Western blot analysis showed enhancement in endothelial Nitric Oxide Synthase (eNOS) phosphorylation in Nrg1beta1 treated ARVCMs, attenuated by Wm. Nrg1beta1 induced a significant increase in calcium transient amplitude (indo-1 ratiometric measure) and accelerated the recovery of cytosolic calcium in the sarcoplasmic reticulum (SR) without affecting whole cell L-Type calcium current. Wm or the Protein Kinase-G (PKG) inhibiting peptide (DT-2) abolished the increase in calcium transient amplitude and the acceleration of calcium recovery induced by Nrg1beta1 treatment. Immunofluorescence analysis revealed that Nrg1beta1 treatment increased phospholamban phosphorylation and the effect was blocked by PI3K and PKG inhibition. Caffeine releasable SR calcium content was also higher during Nrg1beta1 administration. Conclusion Rapid activation of PI3K, eNOS and PKG and a consequent improvement in diastolic calcium can therefore be added to established Nrg1 protective roles. | |
| Volume: | 88 | |
| Fascicolo: | 3 | |
| Pagina iniziale: | 443 | |
| Pagina finale: | 452 | |
| Digital Object Identifier (DOI): | 10.1093/cvr/cvq238 | |
| URL: | http://cardiovascres.oxfordjournals.org/content/88/3/443.long | |
| Parole Chiave: | Neuregulin; ErbB; Calcium handling; NItric oxide; Cardiomyocyte | |
| Rivista: | CARDIOVASCULAR RESEARCH | |
| Appare nelle tipologie: | 03A-Articolo su Rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| Cardiovasc Res-2010-Brero-443-52.pdf | POSTPRINT (VERSIONE FINALE DELL’AUTORE) | Accesso riservato | Utenti riconosciuti Richiedi una copia |
Copyright © 2021